Bio-Rad Laboratories, Inc. (BIO.B)
NYSE: BIO.B · Real-Time Price · USD
396.17
0.00 (0.00%)
Aug 26, 2026, 4:00 PM EDT - Market closed
Bio-Rad Laboratories Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 517 | 529.8 | 488.1 | 403.8 | 434.22 | 470.78 |
Short-Term Investments | 1,102 | 1,011 | 1,176 | 1,203 | 1,356 | 399.14 |
Cash & Short-Term Investments | 1,619 | 1,541 | 1,665 | 1,607 | 1,791 | 869.92 |
Cash Growth | 17.81% | -7.44% | 3.57% | -10.25% | 105.84% | -12.23% |
Accounts Receivable | 441.8 | 460.6 | 452.5 | 489 | 494.65 | 423.54 |
Other Receivables | 8.9 | 11.9 | 13.1 | 11.9 | 11.6 | 2.2 |
Receivables | 450.7 | 472.5 | 465.6 | 500.9 | 506.25 | 425.74 |
Inventory | 780.6 | 740.7 | 760 | 780.5 | 719.32 | 572.24 |
Prepaid Expenses | 147.8 | 136.5 | 122.6 | 140 | 124.18 | 109.14 |
Restricted Cash | 1.6 | 2 | 1.4 | 0.2 | 0.01 | 0.01 |
Other Current Assets | 21.3 | 13.8 | 16.2 | 19.6 | 17.55 | 13.44 |
Total Current Assets | 3,021 | 2,906 | 3,030 | 3,048 | 3,158 | 1,990 |
Property, Plant & Equipment | 671.9 | 709.9 | 688.6 | 723.7 | 679.56 | 716.44 |
Long-Term Investments | 5,723 | 6,103 | 4,838 | 7,697 | 8,830 | 14,386 |
Goodwill | 574.3 | 579.8 | 410.5 | 413.6 | 406.49 | 347.34 |
Other Intangible Assets | 160 | 174.3 | 293.6 | 320.5 | 332.15 | 253.94 |
Other Long-Term Assets | 102.7 | 103.8 | 103.5 | 96.4 | 95.8 | 105.49 |
Total Assets | 10,252 | 10,577 | 9,364 | 12,299 | 13,502 | 17,799 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 143.5 | 129 | 122.3 | 144.6 | 135.04 | 141.94 |
Accrued Expenses | 150.5 | 172.3 | 124.2 | 139.9 | 194.79 | 312.97 |
Current Portion of Long-Term Debt | 400.2 | 0.8 | 0.8 | - | - | - |
Current Portion of Leases | 34.1 | 36.6 | 42.1 | 40.9 | 36.8 | 36.92 |
Current Income Taxes Payable | 74.2 | 36.6 | 31.2 | 35.8 | 32.43 | 10.32 |
Current Unearned Revenue | 52.5 | 48.9 | 47.8 | - | - | 50.85 |
Other Current Liabilities | 106.3 | 92.8 | 99.4 | 161.6 | 169.65 | 127.94 |
Total Current Liabilities | 961.3 | 517 | 467.8 | 522.8 | 568.71 | 680.94 |
Long-Term Debt | 794.6 | 1,193 | 1,191 | 1,190 | 1,188 | 0 |
Long-Term Leases | 141.5 | 154.4 | 140.6 | 175.1 | 163.73 | 186.45 |
Long-Term Unearned Revenue | 13.5 | 14 | 13.7 | - | - | - |
Pension & Post-Retirement Benefits | - | 49.2 | 56.9 | 59.5 | 45.3 | 73.8 |
Long-Term Deferred Tax Liabilities | 982.2 | 1,059 | 818 | 1,476 | 1,770 | 3,065 |
Other Long-Term Liabilities | 185 | 135.9 | 106.6 | 135.5 | 150.61 | 108.39 |
Total Liabilities | 3,078 | 3,123 | 2,795 | 3,558 | 3,886 | 4,114 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | - | - | - | - | 0 | 0 |
Additional Paid-In Capital | 502.9 | 476 | 463.2 | 449.1 | 447.45 | 441.73 |
Retained Earnings | 8,021 | 8,176 | 7,416 | 9,261 | 9,898 | 13,525 |
Treasury Stock | -1,078 | -1,010 | -772.1 | -632.5 | -263.59 | -106.29 |
Comprehensive Income & Other | -271.3 | -189.1 | -538.2 | -336 | -466.82 | -175.55 |
Shareholders' Equity | 7,174 | 7,454 | 6,569 | 8,741 | 9,615 | 13,685 |
Total Liabilities & Equity | 10,252 | 10,577 | 9,364 | 12,299 | 13,502 | 17,799 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 1,370 | 1,385 | 1,375 | 1,406 | 1,388 | 223.38 |
Net Cash (Debt) | 248.1 | 155.9 | 289.8 | 201.6 | 402.56 | 646.54 |
Net Cash Growth | - | -46.20% | 43.75% | -49.92% | -37.74% | -15.53% |
Net Cash Per Share | 9.22 | 5.71 | 10.27 | 6.90 | 13.52 | 21.40 |
Filing Date Shares Outstanding | 26.74 | 26.99 | 28.01 | 28.52 | 29.6 | 29.93 |
Total Common Shares Outstanding | 26.74 | 26.99 | 28.01 | 28.52 | 29.6 | 29.93 |
Working Capital | 2,059 | 2,389 | 2,563 | 2,526 | 2,589 | 1,310 |
Book Value Per Share | 268.30 | 276.16 | 234.52 | 306.51 | 324.89 | 457.20 |
Tangible Book Value | 6,440 | 6,700 | 5,865 | 8,007 | 8,877 | 13,084 |
Tangible Book Value Per Share | 240.84 | 248.22 | 209.39 | 280.77 | 299.93 | 437.12 |
Land | - | 28.9 | 27.8 | 28.4 | 27.8 | 27.94 |
Buildings | - | 449.4 | 426.3 | 419.8 | 393.6 | 385.8 |
Machinery | - | 1,323 | 1,183 | 1,148 | 1,087 | 1,100 |